James Udelson, MD, speaking on Infarct Size as an endpoint in clinical trials
Incorporating Infarct Size Into Trial Composite Endpoints: Implications for Unloading Trials
Video Post
Related Content
 video Acute Limb Ischemia Doubles In-Hospital Mortality Among Patients with Cardiogenic Shock: An Analysis from the...Discussion leaders: Prof. Dr. Med. Bart Meyns (KU Leuven, Belgium) and Kiyotake Ishikawa, MD, PhD (Mount Sinai, USA)
Speaker: Michelle... | 
SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality among...Katherine L. Thayer |